Deciduoid mesothelioma: Cytologic presentation and diagnostic pitfalls by Huang, Cheng Cheng & Michael, Claire W.
Deciduoid Mesothelioma:
Cytologic Presentation and
Diagnostic Pitfalls
Cheng Cheng Huang, M.D. and Claire W. Michael, M.D.*
We report two cases of malignant deciduoid mesothelioma
(MDM), a very rare variant of malignant mesothelioma (MM).
Case 1: An 18-year-old male with no history of asbestos expo-
sure presented with worsening abdominal pain, anorexia, and
vomiting after a motor vehicle accident. A CT scan showed
small amount of ascites and abdominal mass. An exploratory
laparotomy revealed multiple yellow tan, firm nodules on the
peritoneum and omentum. He received palliative treatment and
died 5 months after the diagnosis. Case 2: A 64-year-old female
with history of asbestos exposure initially presented with abdom-
inal distension. CT scan showed abdominal mass with a large
amount of ascites. A diagnostic laparoscopy revealed multiple
peritoneal nodules. She underwent several regimens of chemo-
therapy over a period of 69 months and is still alive to date. In
both cases, features of mesothelial origin were subtle and the
smears showed predominantly single cells with marked nuclear
atypia. The second case also contained few two-dimensional
loose cell clusters with scalloped or hobnail borders. The clus-
ters often exhibited a pseudoacinar structure surrounding a
globular extracellular material. Groups of three to four cells of-
ten formed doublets and triplets with cell-to-cell windows.
Our results show that MDM may not present with the tradi-
tional cytological features described in MM and can manifest
with more nuclear pleomorphism resulting in erroneous diagno-
sis. Recognition of the subtle mesothelial features along with the
appropriate ancillary tests is essential for accurate diagnosis.
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Malignant deciduoid mesothelioma (MDM) is a very rare
variant of mesothelioma. A total of 44 MDM cases have
been documented in the English literature since this entity
was first described in 1985.1,2 In a study of 320 malignant
mesothelioma (MM) cases, only 4 (1.25%) were subclas-
sified as MDM.3 Most of these reports focused on the his-
tological features of MDM.2–8 To date, the cytomorphol-
ogy of MDM has only been described in three single case
reports, in which specimens from fine needle aspiration,1
peritoneal fluid,9 and pericardial fluid10 were studied. In
the present study, we report the cytological features in
two histologically confirmed peritoneal MDM cases pre-
senting with ascites.
Materials and Methods
The standard laboratory methods were used in preparation
of the slides for serous fluid, with the preparation of two
air-dried and Diff-Quik-stained smears, two fixed and Pa-
panicolaou-stained smears and a cell block. All surgical
biopsies and cell block cell pellets were fixed in 10% buf-
fered formalin and embedded in paraffin. The paraffin
embedded blocks were cut into 4-lm-thick sections and
stained with Hematoxylin and Eosin (H&E). The immu-
nohistochemical staining was performed on sections of
the cell blocks according to standard laboratory protocols.
Clinical Presentations and Pathological Findings
Case 1. An 18-year-old white male who suffered from
a side impact motor vehicle accident on December 15,
1997 was sent home without a specified injury. Since that
time he has had vague abdominal pain, anorexia, and
vomiting. He presented to our hospital on January 13,
1998 with increased abdominal pain and anorexia. A CT
scan of the abdomen and pelvis showed small amount of
ascites and multiple nodules on the surface of the perito-
neum and omentum. He was taken to the operating room
with a presumptive acute surgical abdomen on January
14, 1998. An exploratory laparotomy revealed multiple
yellow tan, firm nodules on the peritoneum and omentum.
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An omental tissue biopsy was performed and initially
diagnosed as exuberant reactive changes featuring a prom-
inent mesothelial component. Recurrent ascites was aspi-
rated on January 19, 1998, which was clearly malignant
in nature triggering a second review of the biopsy and the
ultimate diagnosis of MDM. Consequently, the patient
developed worsening abdominal pain and ascites. He was
referred to hospice care where he was managed by pallia-
tive treatment, and announced dead on May 31, 1998. He
had no history of asbestos exposure. However, his uncle
and grandmother both had history of mesothelioma.
A total 8 ml of bloody ascites was obtained by perito-
neocentesis for cytology. The bloody smears (Fig. 1) were
moderate in cellularity with predominantly a single cell
pattern and rare scattered small clusters. Overall the cells
were widely variable in size and shape with striking nu-
clear atypia. The cells exhibited several shapes including:
round, oval, and polygonal. While mostly singly scattered,
occasional doublets and triplets were seen with vague
articulation between the cells (windows). However, cellu-
lar clasping was not detected. Cell-in-cell was occasion-
ally seen. Many tumor cells were large with voluminous
cytoplasm resulting in low N/C ratio in most cells. The
cytoplasm was dense and eosinophilic with no discrete
variation in tone or endo-ectoplasmic demarcation. Sub-
membranous glycogen vacuoles and brush-like borders
were identified at high magnification in occasional cells
(Fig. 1, insert). Binucleated or multinucleated cells were
commonly present and frequently the nuclei were situated
at opposite poles of the cell (Fig. 1). The nuclei were
round, oval or indented, with vesicular yet irregularly
clumped chromatin and prominent macronucleoli (Fig. 2).
Mitotic figures were frequent (Fig. 2, insert).
The histological sections of the omental biopsy showed
sheets of malignant cells with scattered small aggregates
of mature lymphocytes and focal tumor necrosis. The tu-
mor cells (Fig. 3) were large, variable in size, polygonal
to oval in shape with abundant, bright eosinophilic to
glassy cytoplasm. Focal area of the tumor cells showed
finely vacuolated cytoplasm. The nuclei were round to
oval, vesicular with single prominent eosinophilic nucle-
oli. Nuclei were eccentrically situated in many cells. A
brush-like border of cell membrane surface was appreci-
ated in some cells at higher magnification. Binucleated or
multinucleated cells were commonly seen. Mitotic figures
were 1-2 per high power field. Using immunohistochemi-
cal stains on the biopsy, the malignant cells were dif-
fusely positive for pan-cytokeratin, vimentin, and EMA,
mildly positive with calretinin in <25% of the tumor and
negative for HMBE-1, CD45, HMB45, desmin, muscle
Fig. 1. Case 1: The single cells are round, oval or polygonal shaped
with wide variation in size and striking nuclear atypia. A multinucleated
cell shows nuclei situated at opposite poles of the cell. Cell exhibits sub-
membranous glycogen vacuoles and brush-like border (insert). Diff-Quik
stain, 3600. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
Fig. 2. Case 1: The nuclei are round, oval or indented with irregularly
clumped chromatin, and prominent macronucleoli. Mitotic figures are
frequently seen (insert). Papanicolaou stain, 3600. [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
Fig. 3. Case 1: The polygonal shaped cells are large with voluminous,
bright eosinophilic to glassy cytoplasm. The nuclei are round to oval,
with vesicular chromatin and eosinophilic macronucleoli. H&E stain,
3400. [Color figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
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specific actin, progesterone receptor, estrogen receptor,
CD68, human placental lactogen and alpha fetoprotein.
Case 2. A 64-year-old white female school teacher ini-
tially presented with significant weight gain and abdomi-
nal distension on January 2006. The CT scan of her abdo-
men and pelvis performed in February revealed large
amount of ascites and moderate amount of left pleural
fluid. At outside hospital, the ascitic fluid was diagnosed
as adenocarcinoma. Diagnostic laparoscopy was per-
formed in March and revealed multiple peritoneal nodules
which were sampled. The smears of peritoneal fluid and
the slides of tissue biopsy were sent to us for consulta-
tion, and consequently diagnosed as deciduoid mesothe-
lioma. The patient underwent several regimens of chemo-
therapy including six rounds of platinum and pemetrexed
completed in July 2006. In February 2007, she developed
ascites which was aspirated, submitted for cytological
evaluation (current case) and diagnosed as recurrent mes-
othelioma. She consequently received nine cycles of gem-
citabine completed in 2008, 37 cycles of doxorubicin lip-
osomal completed January 2011 and 7 cycles of navelbine
completed in August 2011. Her medical history is signifi-
cant for hypertension, obesity, diabetes, buccal squamous
cell carcinoma diagnosed in July 2009 and metastatic pap-
illary thyroid carcinoma diagnosed in August 2010. She
had history of asbestos exposure in her school and home.
The patient is still alive in December 2011.
A total of 90 ml of bloody ascitic fluid was obtained
by peritoneocentesis for cytology. The smears were mod-
erate in cellularity. The cells manifested as both single
cells and small loosely cohesive clusters. Overall there
was a wide variation in the size and shape of cells. Most
cells were large, pleomorphic with abundant and highly
vacuolated cytoplasm rendering a low N/C ratio to most
cells. Most cells showed fine cytoplasmic vacuoles. Some
cells showed the classic dense cytoplasm but only rare
cells had easily recognizable two tone staining (Fig. 4).
At high magnification, many cells exhibited circumferen-
tial eosinophilic brush border (Fig. 4, insert). The nuclei
were pleomorphic, hyperchromatic with coarse chromatin,
irregular nuclear membrane, and occasionally prominent
one to two nucleoli (Fig. 5). Nuclei were eccentrically sit-
uated in most cells. Double or multinucleated cells and
mitosis were not uncommon. Some cells frequently pre-
sented as doublets and triplets with cell to cell articulation
(windows). Two unusual features were noted in these
articulated cells; first there was frequently striking differ-
ence in the size of the two opposing cells and second a
large cell was sometimes articulated with two or more
smaller cells at one pole (Figs. 5 and 6B). The clusters,
usually composed of 5–12 cells each, were two dimen-
sional, exhibited prominent scalloped or hob-nail borders.
The cluster often formed a pseudoacinar pattern surround-
ing a globular extracellular material which stained pink
on Diff-Quik and cyanophilic on Papanicolaou stain
(Figs. 4 and 5). Histochemical stains for trichrome and
modified Movat pentachrome were performed on the cell
block to further characterize this globular material. The
globules stained blue with trichrome and showed both
yellow and pale green staining by Movat indicating both
old and new collagen.11 Within the small cell clusters, the
cytoplasmic vacuoles were prominent and frequently dis-
figured the groups (Fig. 5). Microcalcifications were also
noted within some of these clusters (Fig. 6A). Because
this fluid was collected after a course of chemotherapy,
EMA and desmin were performed to rule out therapy
related reactive changes. The atypical cells were strongly
Fig. 5. Case 2: Cells exhibit pleomorphic nuclei, hyperchromatic, and
coarse chromatin, with one to two prominent nucleoli. Groups of three
to four cells often form multiple cell-to-cell windows. Disfiguring
cytoplasmic vacuolization is often seen. Papanicolaou stain, 3600.
[Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
Fig. 4. Case 2: Cells are pleomorphic with abundant and highly vacuo-
lated cytoplasm. A cell cluster forms a pseudoacinar structure surround-
ing globular eosinophilic extracellular material, and scalloped or hobnail
border. Membranous brush border is noted (insert). Diff-Quik stain,
3600. [Color figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
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reactive to EMA and negative to desmin favoring its ma-
lignant nature.12 In addition the cellular features were
compared to the previous biopsy and were found to be
morphologically similar.
The omental biopsy showed predominantly sheets of tu-
mor cells with focal necrosis. Focal areas showed dense
fibrotic omentum infiltrated by tumor cells and lympho-
cytes. The tumor cells were large with abundant finely
vacuolated cytoplasm, low N/C ratio and indistinct cell
borders (Fig. 7). Islands of tumor cells with dense eosino-
philic cytoplasm were interspersed within the tissue sec-
tions. The nuclei were pleomorphic with hyperchromatic
coarse chromatin, irregular nuclear membranes and incon-
spicuous nucleoli. Binucleated and multinucleated cells
were common. Mitotic figures were not common. Multi-
ple foci of psammoma bodies or calcifications were pres-
ent in the histology sections. On immunohistochemical
staining, the malignant cells were diffusely and strongly
positive for AE1/3, CAM5.2; focally but strongly positive
for CK5/6 and calretinin. The malignant cells were
focally weakly positive for Ber-EP4 staining. The immu-
nostains for melanoma markers HMB45, MART-1, Melan
A, and tyrosinase were all negative.
Discussion
Malignant mesothelioma (MM) is a relatively rare malig-
nancy. The incidence of mesothelioma is reported to be
2,500 cases in the United States and 5,000 cases in West-
ern Europe annually. Up to 80% of malignant pleural
mesothelioma patients have history of asbestos expo-
sure.13 Peritoneal MM accounts for *30% of MM. In the
United States, its incidence is estimated to be 200–400
new cases annually. It can occur in any age group,
although it mostly affects the 50- to 69-year age group. It
is more common in men, possibly because of the higher
male occupational exposure to asbestos.14 It is estimated
that 57% of patients with a peritoneal MM have a history
of asbestos exposure.15 However, other risk factors such
as radiation exposure are also reported in association with
mesothelioma.16,17 Histologically, there are three major
variants of mesothelioma: epithelioid, sarcomatoid, and
mixed (biphasic). Clinically, the presenting symptoms of
mesothelioma tend to be insidious. Commonly these
patients present with large serous effusions.18 Chemother-
apy is usually the best option for patients with advanced
disease. Cisplatin plus pemetrexed has demonstrated a
significant survival advantage and is considered as first-
line treatment for MM.19 Combination chemotherapy regi-
men of an antifolate (pemetrexed and raltitrexed) and a
platinum-based (cisplatin) agent has shown a median sur-
vival of about 12–14 months.19 Patients with malignant
pleural mesothelioma have a 5-year survival of 15%.19
Because of the peritoneal confinement of MM and low
occurrence of metastasis, an approach consisting of cytor-
eductive surgery and perioperative intraperitoneal chemo-
therapy has been introduced as a curative treatment option
over the last decade with an overall 5-year survival rate
of 29–63%.20
The MDM was first reported in a 13-year-old girl with
primary peritoneal MM.2 Contrary to the original belief
that it is a malignancy that occurs mainly in young
females, it is now known that MDM could occur in both
sexes, at any age and with or without history of asbestos
exposure.1,3,4,6 Clinically, the pleura and peritoneum are
most common sites for primary MDM.21–23 However,
MDM of other locations such as pericardium and sper-
matic cord have also been reported.1,6 MDM tends to be
aggressive with shorter survival.4,23 There are no large
survival studies for MDM due to its rarity. However, the
survival data collected from MDM case reports shows
that approximately more than half the patients died within
Fig. 6. Case 2: Microcalcifications are identified in some cell clusters
(A). A large cell formed cell-to-cell windows with other three smaller
cells (B). Diff-Quik stain, 31,000. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
Fig. 7. Case 2: The cells are large, polygonal with voluminous, finely
vacuolated cytoplasm, low N/C ratio and indistinct cell borders. H&E
stain, 3400. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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1 year, and the remaining patients died within 1–3 years
with only rare patients surviving >4 years after the initial
diagnosis.1 Our patients were different in gender and age
and both presented as primary peritoneal MDM. The
young male patient had no reported history of asbestos
exposure although a family history of MM in both his un-
cle and grandmother suggest environmental exposure. He
received no further therapy and was deceased 5 months
after the diagnosis. The elderly female patient had history
of asbestos exposure both at her home during childhood
and at her work place. She received several rounds of
extensive chemotherapy, and is still alive 69 months after
the initial diagnosis suggesting that chemotherapy had a
positive impact on her prognosis and survival. Overall,
the clinical picture of these two patients is consistent with
that reported in the literature for MDM.1,3,6
Although the cytological features in our two cases were
different, they showed some common features. Both peri-
toneal fluids were moderately cellular with predominantly
single cells and few loose cell clusters. Both showed
striking variation in size and shape and an overall high
degree of nuclear pleomorphism. While mesothelial fea-
tures were not easily recognized, search at higher magnifi-
cation revealed cells showing cellular articulation or win-
dow-like spaces, cell within cell, abundant cytoplasm
with occasional cells exhibiting two tone staining, or
endoectoplasmic differentiation, low N/C ratio, fine sub-
membranous glycogen vacuoles, and brush cytoplasmic
borders. These features are consistent with those of
MM.24 However, other features such as cellular clasping,
morules and spheres were absent particularly in case 1.
The histological features in both cases were similar to
those described in the literature.2–4,25 On the other hand,
our two cases showed some morphological differences
and triggered different differential diagnoses (Table I).
While case 1 had predominantly single cells with dense
cytoplasm, case 2 contained an admixture of single cells
and small clusters with highly vacuolated cytoplasm and
surrounding collagenous cores as confirmed by special
stains, features that are distinctly different from those pre-
viously reported.9,10 Despite the high degree of pleomor-
phism in case 2, its mitotic activity was much lower than
that in case 1. The main differential diagnosis in case 1
especially considering the age and sex should include sar-
coma, seminoma or melanoma. Morphologically, sarcoma
in effusions may round up and lose their spindle shapes.
They are usually vimentin positive and may react with
other stains depending on their line of differentiation.
Seminoma or germ cell tumors are another extremely rare
malignancy in effusion, but tend to have fragile cytoplasm
with fine vacuoles and lack the variation in size. Mela-
noma is also rare and tends to present with features simi-
lar to those seen on aspirates such as intranuclear pseu-
doinclusions, dusty cytoplasm and in occasional cases
melanin. While adenocarcinoma (ADC) is always a possi-
bility, it is far less likely in this age. Immunohistochemi-
cal staining should easily distinguish these entities.
The primary differential in case 2 was metastatic ADC
due to the pleomorphic nuclear features, cellular clusters,
and marked cytoplasmic vacuolation. Indeed the first fluid
Table I. Comparison of Cytomorphological Features in MDM, MM, and ADC
Feature MDM MM ADC
Cellularity Moderate Very high Usually high
Smear pattern
Cell type One cell type One cell type Two cell type
Windows Double or triple windows Frequent No
Cell-in-cell Occasionally Frequent Occasional
Cellular clasping No or rare Prominent No
Individual cell
Size Small to large Small to gigantic Enlarged, less variation
Cytoplasm Abundant Abundant Rare abundant
Most fine vacuoles Rare Variable
Rare two-tone Two-tone One-tone
Submembranous vacuoles Present Present Absent
Brush border Present Present Absent
Nuclei
Size Marled enlarged Marked enlarge Enlarged
Chromatin Vesicular and coarse Variable Vesicular or coarse
Membrane Marked irregularity Variable irregularity Marked irregularity
Nucleoli Eosinophilic macronucleoli Macronucleoli Can be prominent
N/C ratio Low Low High
Double or multinucleated cell Frequent Frequent Rare
Mitosis Frequent Inconspicuous Variable
Cell clusters
Size Small Large Usually small
Shape Loose clusters, 2D Spheres, morules, 3D Tight clusters, spheres, 3D
Border Scalloped or hob-nail Knobby or scalloped border Smooth common border
MDM: malignant deciduoid mesothelioma; MM: malignant mesothelioma; ADC: adenocarcinoma.
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specimen before the tissue biopsy was misdiagnosed as
ADC in initial workup. Subtle mesothelial features were
noted in this case at high magnification and there was
only one cell population. In contrast in ADC, an alien
population is frequently seen in the background of reac-
tive mesothelium. Carcinoma cells tend to show little var-
iation in cellular size and shapes and frequently three
dimensional clusters with smooth common border rather
than scalloped borders (Table I). Because of the history
of chemotherapy in this case and some of the therapy
related changes depicted in the cells as multinucleation,
cytomegally, and large cytoplasmic vacuoles, reactive me-
sothelium had to be ruled out. It should be noted how-
ever, that therapy changes are very seldom seen in effu-
sions. In addition, the features seen in the second effusion
was morphologically similar to those seen in the omental
biopsy and previous fluid. The positive reaction of these
cells to EMA favored their malignant nature.12
On the basis of our two cases, MDM tends to present
with high degree of pleomorphism unlike the epithelioid
MM which generally exhibit subtle atypia and can easily
be underdiagnozed as reactive. Although some mesothe-
lial features as described above can be detected and
should alert the reviewer to the possibility of a mesothe-
lioma variant, not all MM features are seen and therefore,
a definitive diagnosis cannot be rendered without ancillary
tests. Immunohistochemical panel is again essential to
confirm the mesothelial origin of these cells. Calrectinin,
D2-40 and cytokeratin 5/6 are commonly used as meso-
thelial markers. While the latter two markers also react
with non-mesothelial tumors, they are useful when used
in a panel that includes mesothelial markers and markers
that rule out carcinoma. EMA and desmin play a role in
the differential diagnosis between RM and MM. MM has
strong membranous EMA staining in majority of cases
which is rarely present in RM. Desmin is preferentially
expressed in RM and is lost expression in MM. In addi-
tion, several new markers have been reported and may be
useful in the differentiating of RM and MM. Isoform glu-
cose transporter, GlUT-1, is normally undetectable by
immunohistochemistry in normal epithelial tissues and be-
nign tumors, and is increased in expression in a variety of
malignancies. GLUT-1 is expressed in 100% of pleural
MM, 100% of lung squamous cell carcinoma and 93.35%
of lung adenocarcinoma, while is not expressed in RM
cells.26 X-linked inhibitor of apoptosis protein (XIAP) is
also reported for its values in the differential diagnosis of
RM and MM. Strong XIAP staining is often observed in
MM, while RM is usually negative for XIAP by immuno-
staining.27,28 Other ancillary studies such as chromosome
deletion analysis for 1p, 3p, 6q, 9p, and 22q by fluores-
cence in situ hybridization has shown high sensitivity and
high specificity in distinguishing reactive mesothelial cells
and mesothelioma.29,30 Ber-EP4 and Moc-31 are often
included in the panel to differentiate ADC from RM or
MM. However, these two markers can be focally positive
in up to 20% of the MM.31,32 PAX8 is a very highly sen-
sitive and specific marker for peritoneal Mullerian tumor
and is essentially negative in RM or MM.33
In conclusion, we described the cytomorphological and
histological features in two MDM cases arising in the
peritoneal cavity. The cytomorphology of MDM could be
subtle and easily overlooked resulting in misdiagnosis.
However, careful examination should reveal the subtle
mesothelial features and trigger proper ancillary testing
rendering an accurate diagnosis possible.
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